Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Molly Went

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Obesity (2005)|February 19, 2026
Relationship between the microbiome and obesity-associated cancer risk using Mendelian randomisationThomas Yates, Molly Went, Charlie Mills, et al.
Leukemia|January 9, 2020
Genetic predisposition for multiple myelomaMaroulio Pertesi, Molly Went, Markus Hansson, et al.
Scientific Reports|July 26, 2022
Exploiting gene dependency to inform drug development for multiple myelomaMolly Went, Phuc H Hoang, Philip J Law, et al.
Communications Biology|December 1, 2025
Deciphering genetic susceptibility to clear cell renal cell carcinomaMaria Mandelia, Philip J Law, Charlie Mills, et al.
Annals of Human Genetics|February 16, 2019
Regions of homozygosity as risk factors for multiple myelomaMolly Went, Amit Sud, Ni Li, et al.
British Journal of Cancer|September 2, 2025
Mendelian randomisation analysis to discover plasma metabolites mediating the effect of obesity on cancer riskThomas Yates, Molly Went, Charlie Mills, et al.
Blood Cancer Journal|April 8, 2025
Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancySina A Beer, Molly Went, Charlie Mills, et al.
Blood Neoplasia|March 20, 2026
Proteome-wide Mendelian randomization identifies protein associations and therapeutic targets for B-cell malignancyMolly Went, Charlie Mills, Amit Sud, et al.
Research Square|March 30, 2023
Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controlsMolly Went, Amit Sud, Charlie Mills, et al.
Nature Communications|March 26, 2024
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancersMolly Went, Amit Sud, Charlie Mills, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Obesity (2005)|February 19, 2026
Relationship between the microbiome and obesity-associated cancer risk using Mendelian randomisationThomas Yates, Molly Went, Charlie Mills, et al.
Leukemia|January 9, 2020
Genetic predisposition for multiple myelomaMaroulio Pertesi, Molly Went, Markus Hansson, et al.
Scientific Reports|July 26, 2022
Exploiting gene dependency to inform drug development for multiple myelomaMolly Went, Phuc H Hoang, Philip J Law, et al.
Communications Biology|December 1, 2025
Deciphering genetic susceptibility to clear cell renal cell carcinomaMaria Mandelia, Philip J Law, Charlie Mills, et al.
Annals of Human Genetics|February 16, 2019
Regions of homozygosity as risk factors for multiple myelomaMolly Went, Amit Sud, Ni Li, et al.
British Journal of Cancer|September 2, 2025
Mendelian randomisation analysis to discover plasma metabolites mediating the effect of obesity on cancer riskThomas Yates, Molly Went, Charlie Mills, et al.
Blood Cancer Journal|April 8, 2025
Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancySina A Beer, Molly Went, Charlie Mills, et al.
Blood Neoplasia|March 20, 2026
Proteome-wide Mendelian randomization identifies protein associations and therapeutic targets for B-cell malignancyMolly Went, Charlie Mills, Amit Sud, et al.
Research Square|March 30, 2023
Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controlsMolly Went, Amit Sud, Charlie Mills, et al.
Nature Communications|March 26, 2024
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancersMolly Went, Amit Sud, Charlie Mills, et al.
Pageof 3